Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T12577 |
PTP1B-IN-3
|
Phosphatase | Metabolism |
PTP1B-IN-3 是一种具有有选择性和高效性的 PTP1B 抑制剂,具有抗癌活性,抑制 PTP1B 和 TCPTP 。PTP1B-IN-3 可用于研究糖尿病。 | |||
T7356 |
PTP1B-IN-1
PTP1B inhibitor,5-苯基-1,2,5-噻二唑烷-3-酮 1,1-二氧化物 |
Phosphatase | Metabolism |
PTP1B-IN-1 (PTP1B inhibitor) 是一种蛋白质酪氨酸磷酸酶 1B 的有效抑制剂 (IC50 : 1.6 mM) | |||
T61851 | PTP1B-IN-3 diammonium | ||
PTP1B-IN-3 diammonium is a highly effective and orally bioavailable inhibitor of the protein tyrosine phosphatase 1B (PTP1B) enzyme, with an IC50 value of 120 nM for both PTP1B and TCPTP. This compound exhibits potent antidiabetic and anticancer properties, as supported by extensive research [1] [2]. | |||
T35877 |
MurA-IN-1
|
||
MurA-IN-1 (compound 1a) is a PTPRR inhibitor, with IC50 values of 0.23 μM, 0.8 μM, 0.75 μM and 0.09 μM for PTP1B, PTPN5, PTPN7 and PTPRR, respectively[1]. (A family of human MAPK-specific protein tyrosine phosphatases) [1]. Jeyanthy Eswaran, et al. Crystal structures and inhibitor identification for PTPN5, PTPRR and PTPN7: a family of human MAPK-specific protein tyrosine phosphatases. Biochem J. 2006 May 1;395(3):483-91. |